LPS in Recurrent NAFLD

Serum Lipopolysaccharide (LPS) Measurement to Predict Progression of Fibrosis in Liver Transplant Recipients with Hepatitis C Virus

Serum Lipopolysaccharide (LPS) Measurement to Predict Progression of Fibrosis in Liver Transplant Recipients with Hepatitis C Virus.

Are you Eligible? (Inclusion Criteria)

Patients who are either listed for liver transplant or underwent liver transplant for HCV-related cirrhosis.

Specialty Area(s)

Trial Location

NYP/Columbia
New York, NY 10032
United States